Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 12 of 12 for “"Albumin binding domain"”.
-
Using Recombinant PCR to Study Sequence Polymorphisms in a Family of Compact Albumin Binding Domains
Sixteen homologs of a compact albumin binding domain were previously identified in six proteins and four bacterial species. These domains, which exhibit varied affinities for different albumins, have been shown to support bacterial growth in vitro, and may contribute to host specificity. This …
-
Three-dimensional Immobilization of Proteins within Agarose Hydrogels using Two-photon Chemistry
… or the physical interaction between human serum albumin (HSA) and the albumin binding domain (ABD). The use of biological binding pairs also provides mild immobilization conditions, minimizing the risk for bioactivity loss. Similarly, two differentiation factors for retinal stem progenitor cells …
-
ENGINEERED MULTIVALENCY FOR ENHANCED AFFIBODY-BASED HER3 CANCER THERAPY
… as modulation of linker length, valency, and albumin binding domain (ABD) fusion placement allowed for robust retention of ligand bioactivity. We further report significant mechanistic evidence supporting HER3 downregulation as a highly specific phenomenon prompted by HER3 sequestration by …
-
A Novel Antibody Based Capture Matrix Utilizing Human Serum Albumin and Streptococcal Protein G to Increase Capture Efficiency of Bacteria
A novel capture matrix utilizing human serum albumin (HSA) and streptococcal Protein G (PG), which possesses an albumin binding domain (ABD), was used to immobilize antibodies for improved bacterial capture efficiency in immunoassays. Enzyme linked immunosorbent assays (ELISA) were used to …
-
Inhibition of Essential Protein-Protein Interactions in Plasmodium and SARS-CoV-2
… approaches by fusing RON2L with human IgG Fc and albumin binding domain (ABD035) and 2) optimize expression of an in silico designed AMA1-RON2 inhibitor (Pep12) and assess its biochemical and biological activity. We designed Fc and ABD035 fusion constructs of RON2L and Pep12, optimized protein …
-
Developing Modular Protein Therapeutics as Alternatives to Monoclonal Antibodies for Cancer Immunotherapy
… we chose the human tenth fibronectin type III domain (FN3) as the “affinity module” because it is a small (~10 kDa), structurally robust protein domain that has six disordered loops that are similar to the complementarity-determining regions (CDRs) of antibodies. We then oligomerized the …
-
Production of Systems for the Encapsulation of Bioactive Compounds from Photosynthetic Organisms
… a protein-based nanocarrier using bovine serum albumin (BSA) was developed and used to bind curcumin. This approach allowed for curcumin, a hydrophobic molecule, to be indirectly “dissolved” in aqueous media. The protocol developed here involves a near-equimolar protein: curcumin ratio, contrary …
-
Genetically Encoded Albumin Binding Drug Delivery Systems
<p>Albumin is emerging as a promising and versatile carrier to improve the pharmacokinetic and therapeutic profiles of drugs because of its unique physiological properties. The objective of this dissertation is to develop drug delivery systems that bind to and exploit the endogenous albumin in …
-
NOVEL CARRIER PROTEIN AND ITS APPLICATION TO A RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL PEPTIDE
… tag, and the Escherichia coli (E. coli) maltose binding protein carrier (MBP) molecule was sufficient to attenuate RSV A and B replication in vitro by approximately 90 and 80%, respectively. We evaluated the fusion of this His-MBP-Tat-RSVP220-241 mimetic to a more suitable carrier molecule, an …
-
Slowing The Clearance of An Engineered Kallikrein Inhibitor
… is a small protein comprised of the first Kunitz domain of Tissue Factor Pathway Inhibitor and was substituted at seven residues making it a PK-specific inhibitor. rEcall is licensed for HAE treatment, but its short half-life prevents prophylactic application. This project focused on comparing the …
-
Pharmacokinetic Strategies to Enhance the Efficacy of Anti-Cancer Antibodies in Solid Tumors
… transient competitive inhibition of mAb-antigen binding to enable mAb to bypass the binding site barrier (BSB), which limits antibody distribution in solid tumors. Mathematical modeling and simulation were employed to explore desirable characteristics for AIDEs, leading to the prediction that …